title: Letter in response to Dearnaley et al. letter regarding paper: Evaluating the efficacy of statins and angiotensin converting enzyme-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies.
authors.forename: Linda J
authors.initials: LJ
authors.lastname: Wedlake
authors.forename: Foteini
authors.initials: F
authors.lastname: Silia
authors.forename: Barbara
authors.initials: B
authors.lastname: Benton
authors.forename: Amyn
authors.initials: A
authors.lastname: Lalji
authors.forename: Peter
authors.initials: P
authors.lastname: Blake
authors.forename: Diana
authors.initials: D
authors.lastname: Tait
authors.forename: Vincent S
authors.initials: VS
authors.lastname: Khoo
authors.forename: H Jervoise N
authors.initials: HJ
authors.lastname: Andreyev
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D005767:Gastrointestinal Diseases / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D010386:Pelvic Neoplasms / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000517:prevention & control*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors